DNMT3A mutations in myeloproliferative neoplasms von Stegelmann, F, Bullinger, L, Schlenk, R F, Paschka, P, Griesshammer, M, Blersch, C, Kuhn, S, Schauer, S, Döhner, H, Döhner, K

Volltext

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features von Gaidzik, V I, Teleanu, V, Papaemmanuil, E, Weber, D, Paschka, P, Hahn, J, Wallrabenstein, T, Kolbinger, B, Köhne, C H, Horst, H A, Brossart, P, Held, G, Kündgen, A, Ringhoffer, M, Götze, K, Rummel, M, Gerstung, M, Campbell, P, Kraus, J M, Kestler, H A, Thol, F, Heuser, M, Schlegelberger, B, Ganser, A, Bullinger, L, Schlenk, R F, Döhner, K, Döhner, H

Volltext

Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure von Wattad, M, Weber, D, Döhner, K, Krauter, J, Gaidzik, V I, Paschka, P, Heuser, M, Thol, F, Kindler, T, Lübbert, M, Salih, H R, Kündgen, A, Horst, H-A, Brossart, P, Götze, K, Nachbaur, D, Köhne, C-H, Ringhoffer, M, Wulf, G, Held, G, Salwender, H, Benner, A, Ganser, A, Döhner, H, Schlenk, R F

Volltext

Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergrou... von SCHLENK, R. F, BENNER, A, PASOLD, R, DÖHNER, K, GANSER, A, DÖHNER, H, HEIL, G, KRAUTER, J, BÜCHNER, T, SAUERLAND, C, EHNINGER, G, SCHAICH, M, MOHR, B, NIEDERWIESER, D, KRAHL, R

Volltext

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia von Schlenk, R F, Frech, P, Weber, D, Brossart, P, Horst, H-A, Kraemer, D, Held, G, Ringhoffer, M, Burchardt, A, Kobbe, G, Götze, K, Nachbaur, D, Fischer, T, Lübbert, M, Salih, H R, Salwender, H, Wulf, G, Koller, E, Wattad, M, Fiedler, W, Kremers, S, Kirchen, H, Hertenstein, B, Paschka, P, Gaidzik, V I, Teleanu, V, Heuser, M, Thol, F, Döhner, K, Krauter, J, Ganser, A, Döhner, H

Volltext

Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia von Schlenk, R. F., Weber, D., Krzykalla, J., Kindler, T., Wulf, G., Hertenstein, B., Salih, H. R., Südhoff, T., Krauter, J., Martens, U., Wessendorf, S., Runde, V., Tischler, H. J., Bentz, M., Koller, E., Heuser, M., Thol, F., Benner, A., Ganser, A., Döhner, K., Döhner, H.

Volltext

Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism an... von Bullinger, L, Krönke, J, Schön, C, Radtke, I, Urlbauer, K, Botzenhardt, U, Gaidzik, V, Carió, A, Senger, C, Schlenk, R F, Downing, J R, Holzmann, K, Döhner, K, Döhner, H

Volltext

Cell of origin determines clinically relevant subtypes of MLL-rearranged AML von Krivtsov, A V, Figueroa, M E, Sinha, A U, Stubbs, M C, Feng, Z, Valk, P J M, Delwel, R, Döhner, K, Bullinger, L, Kung, A L, Melnick, A M, Armstrong, S A

Volltext

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) von Nagel, Gabriele, Weber, D., Fromm, E., Erhardt, S., Lübbert, M., Fiedler, W., Kindler, T., Krauter, J., Brossart, P., Kündgen, A., Salih, H. R., Westermann, J., Wulf, G., Hertenstein, B., Wattad, M., Götze, K., Kraemer, D., Heinicke, T., Girschikofsky, M., Derigs, H.G., Horst, H. A., Rudolph, C., Heuser, M., Göhring, G., Teleanu, V., Bullinger, L., Thol, F., Gaidzik, V. I., Paschka, P., Döhner, K., Ganser, A., Döhner, Hartmut, Schlenk, R. F.

Volltext

Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia von Döhner, Konstanze, Döhner, Hartmut, Stilgenbauer, Stephan, Benner, Axel, Leupolt, Elke, Kröber, Alexander, Bullinger, Lars, Bentz, Martin, Lichter, Peter

Volltext

GPR56 contributes to the development of acute myeloid leukemia in mice von Daria, D, Kirsten, N, Muranyi, A, Mulaw, M, Ihme, S, Kechter, A, Hollnagel, M, Bullinger, L, Döhner, K, Döhner, H, Feuring-Buske, M, Buske, C

Volltext

DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia von Gaidzik, V I, Weber, D, Paschka, P, Kaumanns, A, Krieger, S, Corbacioglu, A, Krönke, J, Kapp-Schwoerer, S, Krämer, D, Horst, H-A, Schmidt-Wolf, I, Held, G, Kündgen, A, Ringhoffer, M, Götze, K, Kindler, T, Fiedler, W, Wattad, M, Schlenk, R F, Bullinger, L, Teleanu, V, Schlegelberger, B, Thol, F, Heuser, M, Ganser, A, Döhner, H, Döhner, K

Volltext

Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group von Theis, F, Corbacioglu, A, Gaidzik, V I, Paschka, P, Weber, D, Bullinger, L, Heuser, M, Ganser, A, Thol, F, Schlegelberger, B, Göhring, G, Köhne, C-H, Germing, U, Brossart, P, Horst, H-A, Haase, D, Götze, K, Ringhoffer, M, Fiedler, W, Nachbaur, D, Kindler, T, Held, G, Lübbert, M, Wattad, M, Salih, H R, Krauter, J, Döhner, H, Schlenk, R F, Döhner, K

Volltext

Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia von Damm, F, Bunke, T, Thol, F, Markus, B, Wagner, K, Göhring, G, Schlegelberger, B, Heil, G, Reuter, C W M, Püllmann, K, Schlenk, R F, Döhner, K, Heuser, M, Krauter, J, Döhner, H, Ganser, A, Morgan, M A

Volltext

The leukemogenicity of Hoxa9 depends on alternative splicing von Stadler, C R, Vegi, N, Mulaw, M A, Edmaier, K E, Rawat, V P S, Dolnik, A, Bullinger, L, Heilmeier, B, Quintanilla-Fend, L, Spiekermann, K, Hiddemann, W, Döhner, K, Döhner, H, Feuring-Buske, M, Buske, C

Volltext

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis von Schlenk, R F, Stegelmann, F, Reiter, A, Jost, E, Gattermann, N, Hebart, H, Waller, C, Hochhaus, A, Platzbecker, U, Schafhausen, P, Blau, I W, Verbeek, W, Heidel, F H, Werner, M, Kreipe, H, Teleanu, V, Benner, A, Döhner, H, Grießhammer, M, Döhner, K

Volltext

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial von Hammersen, J., Birndt, S., Döhner, K., Reuken, P., Stallmach, A., Sauerbrey, P., La Rosée, F., Pfirrmann, M., Fabisch, C., Weiss, M., Träger, K., Bremer, H., Russo, S., Illerhaus, G., Drömann, D., Schneider, S., La Rosée, P., Hochhaus, A.

Volltext

The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice von Deshpande, A J, Rouhi, A, Lin, Y, Stadler, C, Greif, P A, Arseni, N, Opatz, S, Quintanilla-Fend, L, Holzmann, K, Hiddemann, W, Döhner, K, Döhner, H, Xu, G, Armstrong, S A, Bohlander, S K, Buske, C

Volltext

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group von Jahn, N, Agrawal, M, Bullinger, L, Weber, D, Corbacioglu, A, Gaidzik, V I, Schmalbrock, L, Thol, F, Heuser, M, Krauter, J, Göhring, G, Kündgen, A, Fiedler, W, Wattad, M, Held, G, Köhne, C-H, Horst, H-A, Lübbert, M, Ganser, A, Schlenk, R F, Döhner, H, Döhner, K, Paschka, P

Volltext

Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia von Mar, B G, Bullinger, L, Basu, E, Schlis, K, Silverman, L B, Döhner, K, Armstrong, S A

Volltext